Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 2,346,934 | 2,346,934 | 0 | $63.88M | $77.54M | 57.42% | +$13.66M |
| Lyell Immunopharma, Inc.(LYEL) | 20,162,332 | 20,162,332 | 0 | $39.11M | $44.96M | 33.29% | +$5.85M |
| Prime Medicine, Inc.(PRME) | 1,792,210 | 1,792,210 | 0 | $15.88M | $12.55M | 9.29% | -$3.33M |